Posted: 09/03/2026
NHS Humber Health Partnership Enters Special Measures
Reading Time: 3 minutes
NHS England has placed the NHS Humber Health Partnership (HHP) – the organisation running hospitals across East Yorkshire and North Lincolnshire – into special measures, following serious concerns about how the partnership is being led and how consistently it is delivering patient care. The decision moves HHP into Segment 5, the most intensive level of oversight under the National Oversight Framework.
This affects several major sites, including Hull Royal Infirmary, Castle Hill Hospital in Cottingham, Scunthorpe General Hospital, Grimsby’s Diana Princess of Wales Hospital, and Goole and District Hospital. The partnership has been performing poorly for some time, with a number of its hospitals appearing near the bottom of national rankings.
Background and Leadership Issues
Concerns have been building for months. UNISON has highlighted repeated changes at senior levels, shifting internal structures and uncertainty over who is responsible for what—factors that, understandably, have unsettled staff and raised questions about the quality of decision-making at senior level.
Interim Chief Executive Lyn Simpson, who stepped into the role in July 2025, brought in an external improvement team shortly after her appointment. HHP disclosed Simpson’s unaudited annual salary (£279,162) and confirmed that the improvement team cost £390,100 between August 2025 and January 2026.
Performance Concerns
The issues are not limited to leadership alone. According to further reporting, the partnership has been struggling with major performance pressures, particularly in cancer services. Hull University Teaching Hospitals, one of HHP’s core trusts, now ranks fifth from the bottom out of 134 acute trusts. Only around 53% of cancer patients begin treatment within the two-month target, and by December 2025, 16.5% of patients had waited more than 104 days from urgent referral—serious breaches of national expectations.
These figures illustrate the scale of the challenges now formally recognised through the special-measures designation.
Regulatory Response and Next Steps
HHP has agreed to a set of enforcement undertakings with NHS England. These legally binding commitments require the partnership to strengthen patient safety processes, stabilise service delivery and improve reliability of care. A clinically led improvement plan is already in motion, and recruitment for permanent senior leaders is expected to follow.
Litigation Implications
From a litigation standpoint, HHP’s change of status may influence both ongoing and future matters in several ways:
1. Wider and more detailed disclosure
The enforcement undertakings and improvement programme will inevitably generate a large amount of internal material—governance reviews, performance data, internal communications and reports. These documents may be disclosable and could provide insight into organisational awareness of existing risks, service pressures or known failings relevant to claims involving delay, misdiagnosis or systems-based failings.
2. Systemic-negligence arguments may carry more weight
The performance data—especially the cancer waiting-time breaches—may support the argument that some harm arises from systemic issues rather than isolated clinical mistakes. This may influence breach of duty assessments, expert opinions and causation analysis where treatment delays are central to a case.
3. Disruption in identifying staff and witnesses
Frequent leadership changes and the ongoing transition towards new management can complicate case preparation. Identifying the correct organisational representative or securing statements from individuals with knowledge of earlier events may prove more challenging. Response times may also vary during this adjustment period.
4. Possible shift towards earlier resolution
Trusts placed in special measures often take a more pragmatic approach to litigation. With public scrutiny heightened and an emphasis on transparency, organisations sometimes lean towards resolution—particularly where errors align with issues now formally acknowledged by regulators.
Impact on New Instructions
Clients bringing claims involving delays, continuity-of-care concerns, or insufficient staffing may find that the special-measures context strengthens the evidential foundation of their case. Issues that might previously have been characterised as isolated may now more clearly reflect ongoing systemic pressures within the trust.
FRIENDLY, EFFICIENT LEGAL ADVICE
We’re ready to chat when you are
Drop us an email or give us a call for a no obligation chat to see if we can help.